Suchergebnisse - "Curtin, Nicola"

PubPharm (11)

1

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2014

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

2

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2013

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

3

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2013

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

4

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2013

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

5

Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer

enthalten in: Molecular cancer therapeutics | 2013

von Batey, M. | Zhao, Y. | Kyle, S. | +6

6

Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination

enthalten in: Cancer chemotherapy and pharmacology | 2012

von Tavecchio, M. | Munck, J. | Cano, C. | +2

7

The clinically active PARP inhibitor AG014699 ameliorates cardiotoxicity but does not enhance the efficacy of doxorubicin, despite improving tumor perfusion and radiation response in mice

enthalten in: Molecular cancer therapeutics | 2011

von Ali, M. | Kamjoo, M. | Thomas, H. | +6

8

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

9

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2

10

Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Zaremba, T. | Thomas, H. | Cole, M. | +2